arrow
F

Francesca Lorentino

vita-salute san raffaele university
H指数:20
被引数:1,459

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients

异基因造血干细胞移植受者的人类疱疹病毒6特异性T细胞免疫

2023-09-1511
OAAI
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft- versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases
2023-08-011
PRE
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
2023-04-269
OAAI
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia
2023-01-100
OAAI
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation

限制共享和供体人类白细胞抗原的巨细胞病毒特异性T细胞对异基因造血干细胞移植后巨细胞病毒再激活风险的差异影响

2022-10-0610
OAAI
Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
2022-07-282
OAAI
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors

阿扎胞苷和供体淋巴细胞输注在替代供体异基因造血干细胞移植后复发的急性髓系白血病和骨髓增生异常综合征中

2022-06-176
OAAI
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation
2022-05-1710
OAAI
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study
2022-02-1911
OAAI
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial
2021-09-108
OAAI
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant

异基因干细胞移植中的移植后环磷酰胺和西罗莫司为基础的移植物抗宿主病预防

2021-09-0133
PREAI
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients
2021-07-224
OAAI
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti

等位基因HLA匹配和配对起源是肿瘤血液病中无关造血干细胞移植的有利预后因素: 意大利骨髓捐献者登记处Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari,意大利骨髓捐献者登记处和意大利免疫遗传学协会的一项意大利分析

2021-05-015
OAAI
Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
2020-10-1511
OAAI
Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation
2019-08-3014
OAAI